ReachMD Be part of the knowledge.™

Neurology and Neurosurgery

3343

LikeLikedUnlike

Episodes 16-30 of 136

Audience Q&A with Panel
MinuteCE®
Audience Q&A with Panel
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
- Natalie Kreitzer, MD, MS
  Peer
- Adrian R. Parry-Jones, FRCP, PhD
  Peer
- Hiren C. Patel, PhD, FRCS
  Peer
- David Seiffge, MD
  Peer
- Thorsten Steiner, MD, PhD, MME
  Peer
1.50 program credits
Neurosurgical Management of ICH: Making Sense of ENRICH, SWITCH, STICH and MISTIE
MinuteCE®
Neurosurgical Management of ICH: Making Sense of ENRICH, SWITCH, STICH and MISTIE
- Hiren C. Patel, PhD, FRCS
  Peer
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
- Adrian R. Parry-Jones, FRCP, PhD
  Peer
- Thorsten Steiner, MD, PhD, MME
  Peer
1.50 program credits
Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
MinuteCE®
Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
- Adrian R. Parry-Jones, FRCP, PhD
  Peer
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
- Hiren C. Patel, PhD, FRCS
  Peer
- David Seiffge, MD
  Peer
1.50 program credits
Emerging Data on Reversal and Repletion for Anticoagulated Patients with ICH: The Neurocritical Care Perspective
MinuteCE®
Emerging Data on Reversal and Repletion for Anticoagulated Patients with ICH: The Neurocritical Care Perspective
- Natalie Kreitzer, MD, MS
  Peer
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
- Thorsten Steiner, MD, PhD, MME
  Peer
- Adrian R. Parry-Jones, FRCP, PhD
  Peer
1.50 program credits
Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
MinuteCE®
Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
- David Seiffge, MD
  Peer
- Natalie Kreitzer, MD, MS
  Peer
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
1.50 program credits
ESO Guidelines for the Management of ICH in the Anticoagulated Patient
MinuteCE®
ESO Guidelines for the Management of ICH in the Anticoagulated Patient
- Thorsten Steiner, MD, PhD, MME
  Peer
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
- David Seiffge, MD
  Peer
- Adrian R. Parry-Jones, FRCP, PhD
  Peer
- Natalie Kreitzer, MD, MS
  Peer
1.50 program credits
Evolving Our View of the Coagulation Cascade and Stroke Management
CME/CE
Evolving Our View of the Coagulation Cascade and Stroke Management
- Valeria Caso, MD, PhD
  Peer
- Ashkan Shoamanesh, MD
  Peer
0.25 credits
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
CME/CE
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
- Robert Shin, MD, FANA, FAAN
  Peer
- Enrique Alvarez, MD, PhD
  Peer
- Jiwon Oh, MD, PhD, FRCPC
  Peer
1.00 credits
ATTR Amyloidosis: Familial Vs Wild-Type
MinuteCE®
ATTR Amyloidosis: Familial Vs Wild-Type
- Noel Dasgupta, MD, FACC
  Peer
1.00 program credits
The Multiple Faces of ATTRv-PN
MinuteCE®
The Multiple Faces of ATTRv-PN
- Sami Khella, MD
  Peer
- Marcia Waddington-Cruz, MD, PhD
  Peer
1.00 program credits
MinuteCE®
Heads Up: It Might Be ATTRv Polyneuropathy – A Microlearning Course on Diagnosis and Treatment
- John Berk, MD
  Peer
- Noel Dasgupta, MD, FACC
  Peer
- Sami Khella, MD
  Peer
- Marcia Waddington-Cruz, MD, PhD
  Peer
1.00 credits 8 episodes
Shh…Gene-Silencing Therapies for ATTRv-PN
MinuteCE®
Shh…Gene-Silencing Therapies for ATTRv-PN
- Sami Khella, MD
  Peer
- Marcia Waddington-Cruz, MD, PhD
  Peer
1.00 program credits
ATTRv-PN: A Family Affair?
MinuteCE®
ATTRv-PN: A Family Affair?
- John Berk, MD
  Peer
- Noel Dasgupta, MD, FACC
  Peer
1.00 program credits
Diagnosing ATTRv-PN: What's in Your Toolbox?
MinuteCE®
Diagnosing ATTRv-PN: What's in Your Toolbox?
- Sami Khella, MD
  Peer
1.00 program credits
ATTRv-PN: A Complicated Disease With a Poor Prognosis
MinuteCE®
ATTRv-PN: A Complicated Disease With a Poor Prognosis
- John Berk, MD
  Peer
- Sami Khella, MD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended